<DOC>
	<DOCNO>NCT00509717</DOCNO>
	<brief_summary>The purpose study determine effectiveness maximal support community pharmacy implement pharmaceutical care model improve underprescription treatment persistence regard lipid-lowering medication patient cardiovascular disease .</brief_summary>
	<brief_title>Implementation Pharmacy-Intervention Enhance Prescription Use Lipid-Lowering Drugs</brief_title>
	<detailed_description>Cardiovascular disease main cause death large part world . Next life style change , pharmaceutical treatment keystone treatment cardiovascular disease . Despite strong evidence effectiveness lipid-lowering therapy , less half people eligible treat . With specific medication search community pharmacy database , easy tool detect patient undertreated available . Based tool , pharmaceutical care model improve underprescription treatment persistence regard lipid-lowering medication patient cardiovascular disease construct . Moreover , know yet implement pharmaceutical care model community pharmacy effectively . With multifaceted intervention behaviour health professional change . In study effectiveness maximal support strategy , include interactive educational meeting , reminder , audit feedback , compare minimal implementation strategy .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Hypolipidemic Agents</mesh_term>
	<criteria>pharmacy : resident south Netherlands patient : antiplatelet therapy without lipidlowering medication patient : terminal disease severe mental disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>quality health care</keyword>
	<keyword>prescription , drug</keyword>
	<keyword>anticholesteremic agent</keyword>
	<keyword>community pharmacy service</keyword>
</DOC>